# Amsterdam Molecular Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amsterdam-molecular-therapeutics

- Industry: Biotechnology
- Headquarters: Amsterdam, Netherlands
- Website: www.amtbiopharma.com
- Total disclosed funding: $22M
- Latest round: Series A (Oct 4, 2006)
- Investors on record: 4

## About

Amsterdam Molecular Therapeutics BV (AMT) is a gene therapy company founded by scientists and funds of the Academic Medical Center.

## Funding rounds

- Series A, Oct 4, 2006, $22M — Gilde Healthcare, Advent Venture Partners, Omnes Capital, Forbion

## Investors

- Gilde Healthcare (https://capitalatlas.ai/funds/gilde-healthcare) — Series A
- Advent Venture Partners (https://capitalatlas.ai/funds/advent-venture-partners) — Series A
- Omnes Capital (https://capitalatlas.ai/funds/omnes-capital) — Series A
- Forbion (https://capitalatlas.ai/funds/forbion) — Series A